Prolastin c 1,000 MG/20 ML VLS
Ended Awarded
- Contract number
- SPE2DB25FKEJZ
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,238
Award facts
- Contract value 100% obligated
- $18,238.39 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Prolastin C 1,000 mg/20 ml vials. This firm fixed-price delivery order, valued at $18,238.39, was awarded on August 7, 2025, with an ultimate completion date of August 28, 2025. The contract carries no set-aside designation, allowing DMS Pharmaceutical Group to compete on an unrestricted basis despite its small business status. Performance will occur at the vendor's facility in Park Ridge, Illinois.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, a single-award vehicle valued at $499,999,999 and valid through November 2026. The IDC authorizes DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products supporting Department of Defense healthcare facilities worldwide. Prolastin C, an alpha-1 proteinase inhibitor therapy used to treat alpha-1 antitrypsin deficiency, represents one of the specialized pharmaceutical products within this extensive contract portfolio that supplies branded and generic prescription drugs, biologics, and medical consumables to military health facilities.
Quick answers
Who was awarded contract SPE2DB25FKEJZ?
SPE2DB25FKEJZ was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 7, 2025.
How much is contract SPE2DB25FKEJZ worth?
The government has obligated $18,238 on SPE2DB25FKEJZ.
Is contract SPE2DB25FKEJZ an order under another contract?
Yes. SPE2DB25FKEJZ is a delivery order under SPE2DB24D9223, an indefinite delivery contract.
Was contract SPE2DB25FKEJZ competed?
The extent of competition for SPE2DB25FKEJZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award